Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GSR | P00390 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | PRKCA | P17252 | 3/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3189181 | 0.88 | NAAA (0.52) | SLC18A3NAAAALDH1A1PRKCACHRM2 | |
| SCHEMBL3189185 | 0.88 | NAAA (0.52) | SLC18A3NAAAALDH1A1PRKCACHRM2 | |
| SCHEMBL15167389 | 0.86 | NAAA (0.64) | NAAAPRKCA | |
| SCHEMBL28158465 | 0.86 | NAAA (0.66) | NAAAPRKCA | |
| SCHEMBL2495785 | 0.85 | CHRM2 (0.47) | SLC18A3NAAAALDH1A1GSRCA1 | |
| SCHEMBL15623948 | 0.85 | CHRM2 (0.47) | SLC18A3NAAAALDH1A1GSRCA1 | |
| SCHEMBL16672046 | 0.83 | CHRM2 (0.46) | NAAAALDH1A1GSRCA1CA2 | |
| SCHEMBL7713531 | 0.83 | SLC18A3 (0.43) | SLC18A3NAAAALDH1A1PRKCACHRM2 | |
| SCHEMBL18334321 | 0.81 | CYP19A1 (0.51) | SLC18A3NAAAALDH1A1PRKCACHRM2 | |
| SCHEMBL31459830 | 0.81 | CYP19A1 (0.51) | SLC18A3NAAAALDH1A1PRKCACHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7615233-B2 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | CANON KABUSHIKI KAISHA (JP) | 2009-11-10 | — | — | US | disclosed |
| EP-1275378-B1 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | CANON KK (JP) | 2009-04-15 | — | — | EP | disclosed |
| US-7425432-B2 | Polyhydroxy alkanoate copolymer including within molecule unit having vinyl group or carboxyl group in side chain, and producing method therefor | CANON KABUSHIKI KAISHA (JP) | 2008-09-16 | — | — | US | disclosed |
| EP-1118629-B1 | Polyhydroxyalkanoates and method of producing them by utilizing microorganisms | CANON KK (JP) | 2007-04-25 | — | — | EP | disclosed |
| US-20060211100-A1 | Novel polyhydroxy alkanoate copolymer including within molecule unit having vinyl group or carboxyl group in side chain, and producing method therefor | CANON KABUSHIKI KAISHA (JP) | 2006-09-21 | — | — | US | disclosed |
| WO-2004044213-A1 | NOVEL POLYHYDROXY ALKANOATE COPOLYMER INCLUDING WITHIN MOLECULE UNIT HAVING VINYL GROUP OR CARBOXYL GROUP IN SIDE CHAIN, AND PRODUCING METHOD THEREFOR | CANON KABUSHIKI KAISHA (JP) | 2004-05-27 | — | — | WO | disclosed |
| US-20030194443-A1 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | CANON KABUSHIKI KAISHA (JP) | 2003-10-16 | — | — | US | disclosed |
| US-20030180899-A1 | Process for producing polyhydroxyalkanoates by utilizing microorganisms | HONMA TSUTOMU (JP) | 2003-09-25 | — | — | US | disclosed |
| US-6521429-B2 | Using culture media and yeast extracts | CANON KABUSHIKI KAISHA (JP) | 2003-02-18 | — | — | US | disclosed |
| EP-1275378-A2 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | CANON KABUSHIKI KAISHA (JP) | 2003-01-15 | — | — | EP | disclosed |
| US-20010029039-A1 | Polyhydroxyalkanoates and method of producing them by utilizing mircroorganisms | CANON KABUSHIKI KAISHA (JP) | 2001-10-11 | — | — | US | disclosed |
| EP-1118629-A2 | Polyhydroxyalkanoates and method of producing them by utilizing microorganisms | CANON KABUSHIKI KAISHA (JP) | 2001-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030194443-A1 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | SQLE, FDFT1, CYP51A1 | SLC18A3 2268/4885NAAA 2831/4885ALDH1A1 1502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.